Repaglinide 2 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FQUL0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,613
Award facts
- Contract value 100% obligated
- $11,612.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,612.52 to DMS Pharmaceutical Group Inc. for the supply of Repaglinide 2 mg tablets (90-count) with a delivery deadline of December 23, 2025. This firm fixed-price delivery order was issued without a set-aside designation, allowing the award to be made on a competitive basis. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain, with particular focus on supporting Department of Defense medical operations.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceuticals and medical consumables to military healthcare facilities worldwide. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, with a completion date of December 31, 2036, and includes a 30-month base period with three 30-month option periods. DMS Pharmaceutical Group's established performance across diverse pharmaceutical categories positions it as a key regional prime vendor contractor supporting the Department of Defense's recurring pharmaceutical supply requirements globally.
Quick answers
Who was awarded contract SPE2DR26FQUL0?
SPE2DR26FQUL0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FQUL0 worth?
The government has obligated $11,613 on SPE2DR26FQUL0.
Is contract SPE2DR26FQUL0 an order under another contract?
Yes. SPE2DR26FQUL0 is a delivery order under SPE2DR25D9124, an indefinite delivery contract.
Was contract SPE2DR26FQUL0 competed?
The extent of competition for SPE2DR26FQUL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award